M42 is expanding its healthcare presence in Central Asia as its renal care business, Diaverum, opens its first clinic in Kyrgyzstan and marks 10 years of operations in Kazakhstan.
Located in Bishkek, the new clinic will begin with 15 dialysis stations, operating six days a week, with capacity to expand to 20 stations. It will provide AI-enabled, patient-centred renal care while supporting prevention, early intervention and broader kidney health services.
Click here to join our WhatsApp channel here
Commenting on the opening, Dimitris Moulavasilis, Group Chief Executive Officer of M42, said: “At M42, we are building a global health intelligence platform that brings together clinical expertise, technology, data and genomics to address complex health challenges. Our growth in Central Asia demonstrates how our model can support different healthcare priorities from specialized renal care in Kazakhstan and Kyrgyzstan to advancing prevention-first care in Uzbekistan. Through strong local partnerships, we aim to contribute to more connected, sustainable and future-ready healthcare systems across the region that serve people with their healthcare needs.”
The expansion builds on Diaverum’s operations in Kazakhstan, where it now runs more than 55 clinics serving over 3,400 patients. M42 is also working with Uzbekistan’s Ministry of Health on opportunities related to genomics and the Uzbek Genome Program.
Ziyad Kabli, Chief Operating Officer, Middle East & Asia at M42, said: “Central Asia is an important growth region for M42 and our approach is grounded in long-term collaboration aligned with local healthcare priorities. Kazakhstan demonstrates what can be achieved through sustained commitment, while our entry into Kyrgyzstan expands access to high-quality renal care. Alongside our partnership in Uzbekistan, these developments demonstrate M42’s commitment to more integrated, preventive and data-enabled healthcare across the region.”
Also read: Abu Dhabi Designates Three Centres of Excellence for Breast Cancer Care
